As weight-loss medications become more popular, Nestlé Health Science wants to ensure that consumers who are taking the drugs have access to comprehensive nutritional support. The global leader in ...

Nestlé Health Science is celebrating five years of innovation at its global research and development hub in Bridgewater. Co-located at the company’s U.S. headquarters on Route 202, the Nestlé Product ...

BOSTON--(BUSINESS WIRE)-- Amwell® (NYSE: AMWL), a leader in hybrid health care enablement, today announced a collaboration with Nestlé Health Science, a global leader in the science of nutrition, to ...

CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announced today that it has entered into an agreement ...

LA ROCHELLE, France--(BUSINESS WIRE)--Regulatory News: VALBIOTIS (Paris:ALVAL) (FR0013254851 – ALVAL / PEA/SME eligible ), a Research & Development company committed to scientific innovation for ...

The FINANCIAL — Nestlé on September 27 announced the creation of Nestlé Health Science S.A. and the Nestlé Institute of Health Sciences to pioneer a new industry between food and pharma. These two ...

Nestle wants out of mass-market vitamins. But a move by consumers towards more expensive, science-backed products risks ...

ZURICH (Reuters) -Nestle intends to keep its Health Science unit, Chairman Paul Bulcke said in a newspaper interview published on Sunday, after the food giant announced it was replacing its CEO Mark ...

Codexis, Inc. (NASDAQ:CDXS) entered a purchase deal with Nestlé S.A.(OTC:NSRGY) Nestlé Health Science for CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI). Under the terms ...

EAU CLAIRE, Wis. (WEAU) - Through a $43 million investment, Nestlé Health Science is announcing that they are expanding their manufacturing facility in Eau Claire. According to a media release from ...

Seres Therapeutics has announced a new deal with its longtime partner, Nestlé Health Science, to bring Seres’ lead experimental microbiome drug to the U.S. market. That drug, SER-109, has been tested ...

Nestle’s health science division has continued to motor below the radar in the first half of 2012 and the group is confident of a bright future for the unit. For the first six months of 2012, Nestle ...